| 1 |
LLY
|
Eli Lilly and Company |
8,71% |
24 753 |
18,89 M |
| 2 |
ISRG
|
Intuitive Surgical Inc. |
4,79% |
23 215 |
10,38 M |
| 3 |
ARGX
|
argenx SE |
4,64% |
13 651 |
10,07 M |
| 4 |
SYK
|
Stryker Corporation |
4,61% |
27 071 |
10,01 M |
| 5 |
UNH
|
UnitedHealth Group Incorporated |
4,12% |
25 907 |
8,95 M |
| 6 |
TMO
|
Thermo Fisher Scientific Inc. |
3,82% |
17 086 |
8,29 M |
| 7 |
ABBV
|
AbbVie Inc. |
3,40% |
31 882 |
7,38 M |
| 8 |
ALNY
|
Alnylam Pharmaceuticals Inc. |
3,35% |
15 931 |
7,26 M |
| 9 |
INSM
|
Insmed Incorporated |
3,09% |
46 572 |
6,71 M |
| 10 |
GILD
|
Gilead Sciences Inc. |
2,72% |
53 127 |
5,90 M |
| 11 |
DHR
|
Danaher Corporation |
2,49% |
27 272 |
5,41 M |
| 12 |
BSX
|
Boston Scientific Corporation |
2,43% |
53 962 |
5,27 M |
| 13 |
VRTX
|
Vertex Pharmaceuticals Incorporated |
2,42% |
13 377 |
5,24 M |
| 14 |
AZN US
|
AstraZeneca PLC |
2,31% |
65 286 |
5,01 M |
| 15 |
6160 HK
|
BeOne Medicines Ltd |
1,94% |
157 998 |
4,22 M |
| 16 |
CI
|
The Cigna Group |
1,66% |
12 512 |
3,61 M |
| 17 |
REGN
|
Regeneron Pharmaceuticals Inc. |
1,57% |
6 059 |
3,41 M |
| 18 |
ASND
|
Ascendis Pharma A/S |
1,55% |
16 889 |
3,36 M |
| 19 |
PEN
|
Penumbra Inc. |
1,38% |
11 805 |
2,99 M |
| 20 |
THC
|
Tenet Healthcare Corporation |
1,13% |
12 106 |
2,46 M |
| 21 |
RNA US
|
Avidity Biosciences Inc. |
1,06% |
52 894 |
2,30 M |
| 22 |
CVS
|
CVS Health Corporation |
1,03% |
29 671 |
2,24 M |
| 23 |
ELV
|
Elevance Health Inc. |
1,00% |
6 740 |
2,18 M |
| 24 |
NTRA
|
Natera Inc. |
0,97% |
13 025 |
2,10 M |
| 25 |
HCA
|
HCA Healthcare Inc. |
0,92% |
4 690 |
2,00 M |
| 26 |
UTHR
|
United Therapeutics Corporation |
0,85% |
4 407 |
1,85 M |
| 27 |
COR US
|
Cencora Inc. |
0,76% |
5 251 |
1,64 M |
| 28 |
DGX
|
Quest Diagnostics Incorporated |
0,75% |
8 512 |
1,62 M |
| 29 |
RVMD
|
Revolution Medicines Inc. |
0,71% |
32 896 |
1,54 M |
| 30 |
SRRK
|
Scholar Rock Holding Corporation |
0,71% |
41 151 |
1,53 M |
| 31 |
GH
|
Guardant Health Inc. |
0,69% |
23 937 |
1,50 M |
| 32 |
CNTA
|
Centessa Pharmaceuticals plc |
0,69% |
61 450 |
1,49 M |
| 33 |
BTSG
|
BrightSpring Health Services Inc. |
0,68% |
49 634 |
1,47 M |
| 34 |
IDXX
|
IDEXX Laboratories Inc. |
0,66% |
2 228 |
1,42 M |
| 35 |
SMMT
|
Summit Therapeutics Inc. |
0,65% |
68 527 |
1,42 M |
| 36 |
KYMR
|
Kymera Therapeutics Inc. |
0,65% |
24 802 |
1,40 M |
| 37 |
NBIX
|
Neurocrine Biosciences Inc. |
0,65% |
9 983 |
1,40 M |
| 38 |
CAH
|
Cardinal Health Inc. |
0,62% |
8 584 |
1,35 M |
| 39 |
PTGX
|
Protagonist Therapeutics Inc. |
0,61% |
20 042 |
1,33 M |
| 40 |
IONS
|
Ionis Pharmaceuticals Inc. |
0,58% |
19 250 |
1,26 M |
| 41 |
VEEV
|
Veeva Systems Inc. |
0,57% |
4 143 |
1,23 M |
| 42 |
SNY
|
Sanofi |
0,56% |
25 926 |
1,22 M |
| 43 |
ONC US
|
BeOne Medicines Ltd. |
0,53% |
3 404 |
1,16 M |
| 44 |
AKRO US
|
Akero Therapeutics Inc. |
0,53% |
24 412 |
1,16 M |
| 45 |
CRNX
|
Crinetics Pharmaceuticals Inc. |
0,51% |
26 745 |
1,11 M |
| 46 |
KRYS
|
Krystal Biotech Inc. |
0,51% |
6 206 |
1,10 M |
| 47 |
CYTK
|
Cytokinetics Incorporated |
0,46% |
18 234 |
1,00 M |
| 48 |
SLNO US
|
Soleno Therapeutics Inc. |
0,46% |
14 675 |
992 030,0 |
| 49 |
SOON SW
|
Sonova Holding AG |
0,43% |
3 406 |
934 286,67 |
| 50 |
NUVL
|
Nuvalent Inc. |
0,41% |
10 180 |
880 366,4 |
| 51 |
EXAS
|
Exact Sciences Corporation |
0,40% |
16 021 |
876 508,91 |
| 52 |
VERA
|
Vera Therapeutics Inc. |
0,40% |
30 014 |
872 206,84 |
| 53 |
MRUS US
|
Merus N.V. |
0,40% |
9 185 |
864 767,75 |
| 54 |
EHC
|
Encompass Health Corporation |
0,40% |
6 760 |
858 655,2 |
| 55 |
INCY
|
Incyte Corporation |
0,37% |
9 477 |
803 744,37 |
| 56 |
RYTM
|
Rhythm Pharmaceuticals Inc. |
0,37% |
7 878 |
795 599,22 |
| 57 |
CGON
|
CG Oncology Inc. |
0,37% |
19 744 |
795 288,32 |
| 58 |
MDGL
|
Madrigal Pharmaceuticals Inc. |
0,36% |
1 706 |
782 473,96 |
| 59 |
IMNM
|
Immunome Inc. |
0,35% |
65 604 |
768 222,84 |
| 60 |
CAI
|
Caris Life Sciences Inc. |
0,35% |
24 932 |
754 193,0 |
| 61 |
PCVX
|
Vaxcyte Inc. |
0,33% |
19 884 |
716 221,68 |
| 62 |
AGIO
|
Agios Pharmaceuticals Inc. |
0,33% |
17 752 |
712 565,28 |
| 63 |
ACLX
|
Arcellx Inc. |
0,33% |
8 646 |
709 836,6 |
| 64 |
RVTY
|
Revvity Inc. |
0,33% |
8 058 |
706 283,7 |
| 65 |
IMCR
|
Immunocore Holdings plc |
0,32% |
19 369 |
703 675,77 |
| 66 |
QURE
|
uniQure N.V. |
0,32% |
11 927 |
696 178,99 |
| 67 |
IQV
|
IQVIA Holdings Inc. |
0,32% |
3 659 |
694 990,46 |
| 68 |
ROIV
|
Roivant Sciences Ltd. |
0,31% |
44 415 |
671 998,95 |
| 69 |
4519 JP
|
Chugai Pharmaceutical Co. Ltd. |
0,30% |
14 800 |
656 150,22 |
| 70 |
AXSM
|
Axsome Therapeutics Inc. |
0,29% |
5 249 |
637 491,05 |
| 71 |
BEAM
|
Beam Therapeutics Inc. |
0,28% |
24 779 |
601 386,33 |
| 72 |
ALHC
|
Alignment Healthcare Inc. |
0,27% |
34 030 |
593 823,5 |
| 73 |
RAPP
|
Rapport Therapeutics Inc. |
0,27% |
19 989 |
593 673,3 |
| 74 |
ZLAB
|
Zai Lab Limited |
0,27% |
17 391 |
589 380,99 |
| 75 |
IRON US
|
Disc Medicine Inc. |
0,27% |
8 893 |
587 649,44 |
| 76 |
ABVX
|
Abivax SA |
0,26% |
6 687 |
567 726,3 |
| 77 |
ALKS
|
Alkermes Public Limited Company |
0,25% |
18 181 |
545 430,0 |
| 78 |
CELC
|
Celcuity Inc. |
0,25% |
10 839 |
535 446,6 |
| 79 |
DNLI
|
Denali Therapeutics Inc. |
0,24% |
36 384 |
528 295,68 |
| 80 |
MOH
|
Molina Healthcare Inc. |
0,24% |
2 754 |
527 005,44 |
| 81 |
APGE US
|
Apogee Therapeutics Inc. |
0,24% |
13 010 |
516 887,3 |
| 82 |
MCK
|
McKesson Corporation |
0,24% |
660 |
509 876,4 |
| 83 |
RPRX US
|
Royalty Pharma plc |
0,23% |
14 388 |
507 608,64 |
| 84 |
DXCM
|
DexCom Inc. |
0,23% |
7 526 |
506 424,54 |
| 85 |
BCAX
|
Bicara Therapeutics Inc. |
0,22% |
29 778 |
470 194,62 |
| 86 |
BIIB
|
Biogen Inc. |
0,22% |
3 352 |
469 548,16 |
| 87 |
TARS
|
Tarsus Pharmaceuticals Inc. |
0,21% |
7 834 |
465 574,62 |
| 88 |
RARE
|
Ultragenyx Pharmaceutical Inc. |
0,21% |
15 246 |
458 599,68 |
| 89 |
PRCT
|
Procept Biorobotics Corporation |
0,19% |
11 288 |
402 868,72 |
| 90 |
CLDX
|
Celldex Therapeutics Inc. |
0,19% |
15 561 |
402 563,07 |
| 91 |
ICLR
|
Icon Public Limited Company |
0,18% |
2 228 |
389 900,0 |
| 92 |
BBIO
|
BridgeBio Pharma Inc. |
0,18% |
7 500 |
389 550,0 |
| 93 |
PHVS
|
Pharvaris N.V. |
0,17% |
14 975 |
373 626,25 |
| 94 |
MBX
|
MBX Biosciences Inc. |
0,17% |
21 168 |
370 440,0 |
| 95 |
TEM
|
Tempus AI Inc. |
0,17% |
4 477 |
361 338,67 |
| 96 |
BIO
|
Bio-Rad Laboratories Inc. |
0,16% |
1 234 |
346 001,26 |
| 97 |
BHVN US
|
Biohaven Ltd. |
0,16% |
22 946 |
344 419,46 |
| 98 |
HTFL
|
Heartflow Inc. |
0,15% |
9 606 |
323 337,96 |
| 99 |
PRAX US
|
Praxis Precision Medicines Inc. |
0,15% |
6 057 |
321 021,0 |
| 100 |
ORIC
|
ORIC Pharmaceuticals Inc. |
0,14% |
25 630 |
307 560,0 |
| 101 |
WGS
|
GeneDx Holdings Corp. |
0,14% |
2 730 |
294 130,2 |
| 102 |
TECH
|
Bio-Techne Corporation |
0,13% |
5 000 |
278 150,0 |
| 103 |
KMTS
|
Kestra Medical Technologies Ltd |
0,13% |
11 456 |
272 194,56 |
| 104 |
VRDN
|
Viridian Therapeutics Inc. |
0,11% |
11 500 |
248 170,0 |
| 105 |
JANX
|
Janux Therapeutics Inc. |
0,11% |
10 117 |
247 259,48 |
| 106 |
SYRE
|
Spyre Therapeutics Inc. |
0,11% |
14 141 |
237 003,16 |
| 107 |
RDNT
|
RadNet Inc. |
0,11% |
3 000 |
228 630,0 |
| 108 |
CNC
|
Centene Corporation |
0,11% |
6 400 |
228 352,0 |
| 109 |
GLUE
|
Monte Rosa Therapeutics Inc. |
0,10% |
29 932 |
221 796,12 |
| 110 |
4523 JP
|
Eisai Co. Ltd. |
0,10% |
6 400 |
216 209,93 |
| 111 |
RGEN
|
Repligen Corporation |
0,10% |
1 600 |
213 872,0 |
| 112 |
BCYC US
|
Bicycle Therapeutics plc |
0,09% |
25 602 |
198 159,48 |
| 113 |
GPCR
|
Structure Therapeutics Inc. |
0,09% |
6 977 |
195 356,0 |
| 114 |
ORKA
|
Oruka Therapeutics Inc. |
0,09% |
9 891 |
190 203,93 |
| 115 |
WVE
|
Wave Life Sciences Ltd. |
0,08% |
24 968 |
182 765,76 |
| 116 |
LENZ US
|
LENZ Therapeutics Inc. |
0,08% |
3 800 |
177 004,0 |
| 117 |
IDYA
|
IDEAYA Biosciences Inc. |
0,08% |
6 339 |
172 484,19 |
| 118 |
RLAY
|
Relay Therapeutics Inc. |
0,08% |
32 881 |
171 638,82 |
| 119 |
REPL
|
Replimune Group Inc. |
0,08% |
40 761 |
170 788,59 |
| 120 |
BBOT US
|
BridgeBio Oncology Therapeutics Inc. |
0,08% |
14 485 |
167 736,3 |
| 121 |
ACAD
|
Acadia Pharmaceuticals Inc. |
0,07% |
7 600 |
162 184,0 |
| 122 |
XNCR
|
Xencor Inc. |
0,07% |
13 179 |
154 589,67 |
| 123 |
ELVN
|
Enliven Therapeutics Inc. |
0,07% |
7 480 |
153 115,6 |
| 124 |
HIMS
|
Hims and Hers Health Inc. |
0,07% |
2 600 |
147 472,0 |
| 125 |
KYTX US
|
Kyverna Therapeutics Inc. |
0,07% |
24 113 |
144 678,0 |
| 126 |
BBNX US
|
Beta Bionics Inc. |
0,07% |
7 125 |
141 573,75 |
| 127 |
MIRM
|
Mirum Pharmaceuticals Inc. |
0,06% |
1 900 |
139 289,0 |
| 128 |
SION
|
Sionna Therapeutics Inc. |
0,06% |
4 726 |
138 991,66 |
| 129 |
DNTH
|
Dianthus Therapeutics Inc. |
0,06% |
3 302 |
129 933,7 |
| 130 |
ALEC US
|
Alector Inc. |
0,06% |
43 704 |
129 363,84 |
| 131 |
KOD
|
Kodiak Sciences Inc. |
0,06% |
7 500 |
122 775,0 |
| 132 |
IMRX US
|
Immuneering Corporation |
0,06% |
17 357 |
121 499,0 |
| 133 |
WAT
|
Waters Corporation |
0,06% |
400 |
119 924,0 |
| 134 |
MDWD US
|
MediWound Ltd |
0,05% |
6 487 |
116 895,74 |
| 135 |
URGN
|
UroGen Pharma Ltd. |
0,05% |
5 400 |
107 730,0 |
| 136 |
ALLO
|
Allogene Therapeutics Inc. |
0,05% |
81 376 |
100 906,24 |
| 137 |
MLTX
|
MoonLake Immunotherapeutics |
0,05% |
13 971 |
100 172,07 |
| 138 |
IMTX
|
Immatics N.V. |
0,04% |
10 404 |
88 642,08 |
| 139 |
NAMS US
|
NewAmsterdam Pharma Company N.V. |
0,04% |
2 900 |
82 476,0 |
| 140 |
VSTM US
|
Verastem Inc. |
0,04% |
9 100 |
80 353,0 |
| 141 |
RCKT US
|
Rocket Pharmaceuticals Inc. |
0,04% |
23 535 |
76 724,1 |
| 142 |
VYGR US
|
Voyager Therapeutics Inc. |
0,03% |
15 964 |
74 551,88 |
| 143 |
ALSEN FP
|
Sensorion |
0,03% |
182 870 |
73 643,99 |
| 144 |
CBIO US
|
Crescent Biopharma Inc. |
0,03% |
5 959 |
70 852,51 |
| 145 |
LBRX
|
LB Pharmaceuticals Inc |
0,03% |
4 390 |
69 318,1 |
| 146 |
IOVA
|
Iovance Biotherapeutics Inc. |
0,03% |
31 687 |
68 760,79 |
| 147 |
ANNX
|
Annexon Inc. |
0,03% |
22 109 |
67 432,45 |
| 148 |
TRDA
|
Entrada Therapeutics Inc |
0,03% |
11 625 |
67 425,0 |
| 149 |
AURA US
|
Aura Biosciences Inc. |
0,03% |
10 426 |
64 432,68 |
| 150 |
OBIO US
|
Orchestra Biomed Holdings Inc. |
0,02% |
13 354 |
33 117,92 |
| 151 |
DNA US
|
Ginkgo Bioworks Holdings Inc. |
0,01% |
1 971 |
28 737,18 |
| 152 |
PRLD US
|
Prelude Therapeutics Incorporated |
0,01% |
17 428 |
25 096,32 |
| 153 |
GBIO US
|
Generation Bio Co. |
0,01% |
3 769 |
23 066,28 |
| 154 |
CLYM US
|
Climb Bio Inc. |
0,01% |
9 200 |
18 492,0 |
| 155 |
CABA US
|
Cabaletta Bio Inc. |
0,00% |
2 887 |
6 755,58 |
| 156 |
RVMDW
|
Revolution Medicines Inc. |
0,00% |
4 502 |
1 350,6 |
| 157 |
WGSWW
|
GeneDx Holdings Corp. |
0,00% |
4 862 |
532,88 |
| 158 |
SLGCW
|
SomaLogic Inc. |
0,00% |
2 050 |
79,8 |